Euromonitor's Black Friday Sale is now LIVE until Monday 30th November 2020. 15% DISCOUNT off all 20,000+ Reports within our Store. Any queries? Please use live chat on-site or email us on info@euromonitor.com

GlaxoSmithKline Plc

Company Profile

Company Profile

GlaxoSmithKline Plc in Consumer Health

Nov 2020

GSK maintained its market-leading position in 2020, on the back of its merger with Pfizer. While Advil sales faltered, Panadol and Centrum buoyed the company’s growth globally in 2020 and Voltaren’s Rx-to-OTC switch benefited the US. Emergen-C was ...

US$570
Add to cart View details
Company Profile

Company Profile

GlaxosmithklinePlc in Consumer Health

Sep 2019

In August 2019, GlaxoSmithKline Plc (GSK) announced the final approval of its joint venture with Pfizer Inc, creating an unrivalled consumer health powerhouse with a leadership position in OTC drugs in six of seven regions worldwide. This profile ...

US$570
Add to cart View details
Company Profile

Company Profile

GlaxosmithKline Plc in Beauty and Personal Care

Aug 2015

GSK has made solid gains in oral care over 2009-2014. Sensodyne, through its advanced dentist-inspired results and wide global coverage, pushed growth ahead, making it a power brand in the field. Conversely, its staple brand Aquafresh saw slower ...

US$570
Add to cart View details
Company Profile

Company Profile

Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture

Sep 2014

Among the largest pharmaceutical companies, both GlaxoSmithKline Plc and Novartis AG are global leaders in consumer health. While manufacturing disruptions and unfavourable market conditions in key geographies have hindered recent performance, these ...

US$570
Add to cart View details

Market Research Solutions

Our Passport market research database provides market context, competitor insight and future trends analysis to help you make clear, confident decisions.

Learn More